These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17622926)
61. Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis. Tan Y; Cao L; Lv JC; Yan Y; Zuo L; Wang M; Yu L; Yu F; Zhao MH Thromb Haemost; 2009 Dec; 102(6):1282-4. PubMed ID: 19967164 [No Abstract] [Full Text] [Related]
66. Heparin-induced thrombocytopenia in the ICU: an overview. Sakr Y Crit Care; 2011; 15(2):211. PubMed ID: 21457505 [No Abstract] [Full Text] [Related]
67. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia. Bream-Rouwenhorst HR; Hobbs RA Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000 [TBL] [Abstract][Full Text] [Related]
68. Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies. Schreiber C; Dietrich W; Braun S; Kostolny M; Eicken A; Lange R Clin Res Cardiol; 2006 Jul; 95(7):379-82. PubMed ID: 16779503 [No Abstract] [Full Text] [Related]
69. Measurement of heparin-dependent platelet antibodies in the diagnosis of heparin-induced thrombocytopenia: fact or fiction? Parker RI Crit Care Med; 2007 Jul; 35(7):1784-5. PubMed ID: 17581366 [No Abstract] [Full Text] [Related]
70. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. Warkentin TE; Sheppard JI; Moore JC; Kelton JG J Thromb Haemost; 2010 Jan; 8(1):216-8. PubMed ID: 19818000 [No Abstract] [Full Text] [Related]
71. Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: use of heparin and epoprostenol combined with on-line monitoring of platelet function. Mertzlufft F; Kuppe H; Koster A J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):304-8. PubMed ID: 10890486 [No Abstract] [Full Text] [Related]
72. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia. Shelat SG; Tomaski A; Pollak ES Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512 [TBL] [Abstract][Full Text] [Related]
73. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade. Durand M; Lecompte T; Hacquard M; Carteaux JP Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401 [TBL] [Abstract][Full Text] [Related]
74. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery. Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189 [TBL] [Abstract][Full Text] [Related]
75. Heparin-induced thrombocytopenia associated with intra-tumour haemorrhage in cavernous sinus after cardiac myxoma surgery. Tsai HC; Yen HC; Hsu JC; Lin CL Br J Neurosurg; 2009 Feb; 23(1):95-6. PubMed ID: 19234918 [TBL] [Abstract][Full Text] [Related]